[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Franklin Financial Services Corporation (FRAF) filed a Form 4 disclosing that director Daniel J. Fisher acquired 313 common shares on 06/23/2025 at an implied price of $34.60 per share, totaling roughly $10.8 thousand. The shares were issued in lieu of cash compensation for a portion of Fisher’s board fees. Following the transaction, Fisher directly owns 29,276 shares, a figure that includes previously reported unvested restricted stock units. No derivative securities were involved.

The filing represents a routine compensation-related share issuance rather than an open-market purchase, but it still modestly increases insider equity alignment without altering control dynamics or signaling material changes to FRAF’s capital structure.

Positive

• Director increases direct share ownership, modestly aligning board interests with shareholders.
• Equity-for-fees structure conserves issuer cash while maintaining compensation value.

Negative

• Transaction size is immaterial (~$10.8k) and unlikely to influence market perception.
• Not an open-market purchase; therefore, provides limited incremental confidence signal compared with voluntary buys.

Insights

Financial Analyst

TL;DR: Minor director stock-for-fees grant; immaterial to valuation, marginally positive for alignment.

The acquisition is worth about $10.8k—trivial against FRAF’s market capitalization. Because the shares replace cash, there is no incremental cash outlay by the insider, limiting the usual bullish signal from direct open-market buys. Nonetheless, the grant raises Fisher’s stake to 29,276 shares, strengthening board-shareholder alignment at negligible dilution. From a valuation or earnings standpoint, the event is not impactful; investors may view it as neutral-to-slightly positive sentiment.

Corporate Governance Specialist

TL;DR: Routine equity compensation improves alignment; governance stance unchanged.

Paying a portion of director fees in stock is a common governance practice that encourages long-term oversight focus. The absence of derivative activity and the direct holding form reduce complexity and potential conflict. Because the share count is de minimis relative to outstanding shares, voting power shift is immaterial. Overall effect on governance quality is positive but not materially impactful to shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2572	129886.00	215453899	06/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	06/15/2025	Restricted Stock Vesting	Issuer			2572	06/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	03/31/2025	3236	89863.72
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	04/14/2025	3236	92937.92
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	04/28/2025	3236	97694.84
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	05/12/2025	3235	181160.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	05/27/2025	3233	180627.71
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	5451	309616.80
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	2572	153677.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many FRAF shares did director Daniel J. Fisher acquire?

He received 313 common shares on 06/23/2025.

What was the implied price for the shares acquired by the FRAF director?

The shares were valued at approximately $34.60 each.

What is Daniel J. Fisher’s total FRAF shareholding after the transaction?

Following the grant, he directly owns 29,276 shares, including unvested RSUs.

Why were the shares issued to the FRAF director?

They were issued in lieu of cash for a portion of the director’s fees.

Were any derivative securities involved in this Form 4 filing for FRAF?

No, no derivative securities were reported.